Sarepta Gene Therapy Deaths

News

FDA asks Sarepta to stop shipping gene therapy

Gene therapy maker Sarepta tells FDA it won’t halt shipments despite patient deaths

Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene therapy.

MedPage Today · 8h

Drugmaker Refuses FDA's Request to Pull Gene Therapy Tied to Patient Deaths

BioPharma Dive · 5h

FDA asks Sarepta to stop shipping Duchenne gene therapy

Fierce Biotech9h

Sarepta LGMD trials all hit by FDA hold amid newly surfaced safety concerns over gene therapy

The Sarepta saga continues, with the FDA slapping a clinical hold across all of the company’s investigational limb girdle ...

14h

Sarepta Stock Continues to Fall After Patient Death Linked to Investigational Gene Therapy

Also on Friday, the Food and Drug Administration informally requested that Sarepta voluntarily pause shipments of another gene therapy, Elevidys, which is approved to treat a different type of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

FDA asks Sarepta to stop shipping gene therapy

Sarepta LGMD trials all hit by FDA hold amid newly surfaced safety concerns over gene therapy

Sarepta Stock Continues to Fall After Patient Death Linked to Investigational Gene Therapy

Trending now